Literature DB >> 16720555

Hypereosinophilia in a patient with invasive thymoma with clonal T-lymphocyte expansion expressing CD4, CD8, and CD25 antigens.

Masahiko Sumi1, Kosuke Nunoda, Tomonori Mizutani, Yuko Ishii, Akihiko Gotoh, Yukihiko Kimura, Yasuhiro Suga, Tatsuo Ohira, Kuniharu Miyajima, Hiromi Serizawa, Kiyoshi Mukai, Harubumi Kato, Kazuma Ohyashiki.   

Abstract

We report the case of a patient with hypereosinophilia and invasive thymoma harboring probable clonal proliferation of CD4+, CD8+, and CD25+ T-lymphocytes. A 64-year-old woman had eosinophilia (14.1 x 10(9)/L) and an anterior mediastinal tumor with elevated levels of serum immunoglobulin E (609.8 mg/dL) and interleukin 5 (239 pg/mL). Bone marrow aspirate showed marked infiltration by morphologically normal eosinophils with a normal karyotype but no FIP1L1-PDGFRA fusion gene. Flow cytometric analysis revealed an increasing number of CD3+/CD25+ lymphocytes in the peripheral blood, and the resected thymoma had infiltrated lymphocytes with CD4/CD8/CD25 antigens. Moreover, the thymoma had T-cell receptor rearrangements with a cytogenetically clonal nature, ie, t(2;4)(p22;q26). Although the number of patients with thymoma showing hypereosinophilia is small, this case suggests that a subset of patients with thymoma may have clonal expansion of T-lymphocytes with abnormal phenotypes that affect clinical manifestations, including hypereosinophilia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16720555     DOI: 10.1532/IJH97.05146

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  13 in total

1.  A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.

Authors:  Jan Cools; Daniel J DeAngelo; Jason Gotlib; Elizabeth H Stover; Robert D Legare; Jorges Cortes; Jeffrey Kutok; Jennifer Clark; Ilene Galinsky; James D Griffin; Nicholas C P Cross; Ayalew Tefferi; James Malone; Rafeul Alam; Stanley L Schrier; Janet Schmid; Michal Rose; Peter Vandenberghe; Gregor Verhoef; Marc Boogaerts; Iwona Wlodarska; Hagop Kantarjian; Peter Marynen; Steven E Coutre; Richard Stone; D Gary Gilliland
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

2.  Clonal Th2 lymphocytes in patients with the idiopathic hypereosinophilic syndrome.

Authors:  F Roufosse; L Schandené; C Sibille; K Willard-Gallo; B Kennes; A Efira; M Goldman; E Cogan
Journal:  Br J Haematol       Date:  2000-06       Impact factor: 6.998

3.  Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia.

Authors:  H U Simon; S G Plötz; R Dummer; K Blaser
Journal:  N Engl J Med       Date:  1999-10-07       Impact factor: 91.245

4.  Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis.

Authors:  Anna Balandina; Sandrine Lécart; Philippe Dartevelle; Abdelhadi Saoudi; Sonia Berrih-Aknin
Journal:  Blood       Date:  2004-09-28       Impact factor: 22.113

5.  Oligoclonal peripheral T-cell lymphocytosis as a result of aberrant T-cell development in a cortical thymoma.

Authors:  D de Jong; D J Richel; C Schenkeveld; L Boerrigter; L J van 't Veer
Journal:  Diagn Mol Pathol       Date:  1997-08

6.  Pure red cell aplasia with thymona: evidence of T-cell clonal disorder.

Authors:  M Masuda; Y Arai; T Okamura; H Mizoguchi
Journal:  Am J Hematol       Date:  1997-04       Impact factor: 10.047

7.  Eosinophilia associated with proliferation of CD(3+)4-(8-) alpha beta+ T cells with chromosome 16 anomalies.

Authors:  K Kitano; N Ichikawa; B Mahbub; M Ueno; T Ito; S Shimodaira; H Kodaira; F Ishida; H Kobayashi; H Saito; Y Okubo; H Enokihara; K Kiyosawa
Journal:  Br J Haematol       Date:  1996-02       Impact factor: 6.998

Review 8.  Inhibition of programmed eosinophil death: a key pathogenic event for eosinophilia?

Authors:  H U Simon; K Blaser
Journal:  Immunol Today       Date:  1995-02

9.  Increased thymocyte CD4+CD8+ cells and T-cell receptor beta gene rearrangements in thymoma.

Authors:  Motoki Sakuraba; Toshiko Motoji; Sumio Nitta; Hideaki Mizoguchi; Takamasa Ohnuki
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-10

10.  Thymoma with bone marrow eosinophilia.

Authors:  R J Fitzmaurice; D L Gardner
Journal:  J R Soc Med       Date:  1990-04       Impact factor: 18.000

View more
  1 in total

1.  Clinical features of hypereosinophilic syndrome: FIP1L1-PDGFRA fusion gene-positive disease is a distinct clinical entity with myeloproliferative features and a poor response to corticosteroid.

Authors:  Keisuke Miyazawa; Naoki Kakazu; Kazuma Ohyashiki
Journal:  Int J Hematol       Date:  2007-01       Impact factor: 2.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.